Evidence map›Paper›PMID 42164825›Full record

ArticleMolecular syndromology2026

Genotypic and Phenotypic Characteristics of Turkish Patients with Hereditary Fructose Intolerance.

Mustafa Kılıç, Esra Sayar, Suzan İcil, Abdullah Sezer

Abstract read
In one paragraph

Article in Molecular syndromology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mustafa KılıçDepartment of Pediatrics, Metabolism Unit, University of Health Sciences, Ankara Etlik City Hospital, Ankara, Türkiye.
Esra SayarDepartment of Pediatrics, Metabolism Unit, Ankara Etlik City Hospital, Ankara, Türkiye.
Suzan İcilDepartment of Pediatrics, Metabolism Unit, Ankara Etlik City Hospital, Ankara, Türkiye.
Abdullah SezerDepartment of Medical Genetics, Ankara Etlik City Hospital, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hereditary fructose intolerance (HFI) is an autosomal recessive inherited metabolic disorder characterized by a deficiency of the fructose-1-phosphate aldolase (aldolase B) enzyme, caused by biallelic pathogenic variants in the Methods: We retrospectively analyzed the demographic, clinical, biochemical, and molecular genetic characteristics of 9 patients from eight unrelated Turkish families diagnosed with HFI over the past 10 years at a single center. Results: Patients with HFI showed an aversion to sugar-containing foods and generally had a favorable prognosis. The most common presenting complaints or reasons for referral to our clinic in this cohort were vomiting, hepatosteatosis, and elevated transaminases. Fructose aversion was present in all patients, representing a protective adaptive behavior rather than a complaint, and was therefore not reported as a symptom. Hypoglycemic syncope was observed in only 1 patient, while no significant hypoglycemia or metabolic acidosis was detected in the others. Urinary reducing substances and urine sugar chromatography were negative, likely due to the avoidance of fructose-containing foods. The p.Ala150Pro and p.Ala175Asp were identified as the most frequent variants. Homozygous variants (87.5%) were more common than compound heterozygous variants (12.5%). Conclusion: Genetic analysis of the

Indexed as

ALDOBAldolase BFructoseFructose-1-phosphate aldolaseHereditary fructose intoleranceHypoglycemia

Identifiers

PMID42164825
PMCPMC13186570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.